Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Zhengye Biological Products has commercialized over 40 veterinary vaccines, with a strong domestic presence and growing export business. Recent clinical results enabled the launch of innovative vaccines, including two Category I New Veterinary Drug Certificates for groundbreaking vaccines in cattle (Mycoplasma bovis) and poultry, plus the pending launch of an inactivated rabies vaccine for companion animals[1][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Zhengye Biological Products.